Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.49 CAD | +5.06% | +1.63% | +492.86% |
05-22 | Medicenna to Present Clinical Update on MDNA11 ABILITY-1 Trial at Sachs Oncology Innovation Forum | MT |
05-13 | Medicenna Says ABILITY-1 Abstract Withdrawn by ASCO Program Committee | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+492.86% | 130M | |
+64.23% | 55.07B | |
-2.31% | 41.79B | |
+44.36% | 40.22B | |
-8.29% | 28.17B | |
+11.97% | 26.28B | |
-21.16% | 18.93B | |
+7.54% | 13.03B | |
+27.17% | 12.26B | |
+25.72% | 12.21B |
- Stock Market
- Equities
- MDNA Stock
- News Medicenna Therapeutics Corp.
- HC Wainwright Adjusts Medicenna Therapeutics' Price Target to $5 from $7, Keeps Buy Rating